Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Astellas and Universal Cells Ink $124M R&D Pact for Undisclosed Indication October 19, 2017 Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults February 14, 2017 Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018
Gilead Announces 144-Week Data Evaluating Safety And Efficacy Of Genvoya For Treatment Of HIV-1 In Treatment-Na??ve Adults February 14, 2017
Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018
